148 related articles for article (PubMed ID: 38238547)
1. Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022.
Wang CX; Kohli R; Olaker VR; Terebuh P; Xu R; Kaelber DC; Davis PB
Mol Psychiatry; 2024 May; 29(5):1350-1360. PubMed ID: 38238547
[TBL] [Abstract][Full Text] [Related]
2. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
3. Association of Recent SARS-CoV-2 Infection With New-Onset Alcohol Use Disorder, January 2020 Through January 2022.
Olaker VR; Kendall EK; Wang CX; Parran TV; Terebuh P; Kaelber DC; Xu R; Davis PB
JAMA Netw Open; 2023 Feb; 6(2):e2255496. PubMed ID: 36757694
[TBL] [Abstract][Full Text] [Related]
4. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
5. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.
Nemani K; Li C; Olfson M; Blessing EM; Razavian N; Chen J; Petkova E; Goff DC
JAMA Psychiatry; 2021 Apr; 78(4):380-386. PubMed ID: 33502436
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections.
Clift AK; Ranger TA; Patone M; Coupland CAC; Hatch R; Thomas K; Hippisley-Cox J; Watkinson P
JAMA Psychiatry; 2022 Jul; 79(7):690-698. PubMed ID: 35544272
[TBL] [Abstract][Full Text] [Related]
7. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
COVID-19 Mental Disorders Collaborators
Lancet; 2021 Nov; 398(10312):1700-1712. PubMed ID: 34634250
[TBL] [Abstract][Full Text] [Related]
8. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach.
Estrela M; Silva TM; Gomes ER; Piñeiro M; Figueiras A; Roque F; Herdeiro MT
J Epidemiol Community Health; 2022 Apr; 76(4):335-340. PubMed ID: 34625519
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
[TBL] [Abstract][Full Text] [Related]
10. Covid-19-related stressors, mental disorders, depressive and anxiety symptoms: a cross-sectional, nationally-representative, face-to-face survey in Serbia.
Marić NP; Lazarević LJB; Priebe S; Mihić LJ; Pejović-Milovančević M; Terzić-Šupić Z; Tošković O; Vuković O; Todorović J; Knežević G
Epidemiol Psychiatr Sci; 2022 May; 31():e36. PubMed ID: 35607805
[TBL] [Abstract][Full Text] [Related]
11. Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study.
Matta J; Robineau O; Wiernik E; Carrat F; Severi G; Touvier M; Gouraud C; Ouazana Vedrines C; Pitron V; Ranque B; Pignon B; Hoertel N; Kab S; Goldberg M; Zins M; Lemogne C
Mol Psychiatry; 2023 Oct; 28(10):4261-4271. PubMed ID: 37464077
[TBL] [Abstract][Full Text] [Related]
12. Anxiety and depressive disorders among patients with esophageal cancer in Taiwan: a nationwide population-based study.
Hu LY; Ku FC; Wang YP; Shen CC; Hu YW; Yeh CM; Chen PM; Chiang HL; Lu T; Chen TJ; Teng CJ; Liu CJ
Support Care Cancer; 2015 Mar; 23(3):733-40. PubMed ID: 25179690
[TBL] [Abstract][Full Text] [Related]
13. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
[TBL] [Abstract][Full Text] [Related]
14. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study.
Cheng CM; Hsu JW; Huang KL; Bai YM; Su TP; Li CT; Yang AC; Chang WH; Chen TJ; Tsai SJ; Chen MH
J Affect Disord; 2015 Jun; 178():60-5. PubMed ID: 25795537
[TBL] [Abstract][Full Text] [Related]
15. Effects of the COVID-19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes.
Kowall B; Kostev K; Landgraf R; Hauner H; Bierwirth R; Rathmann W
Diabet Med; 2022 Aug; 39(8):e14852. PubMed ID: 35426166
[TBL] [Abstract][Full Text] [Related]
16. Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.
Lui DTW; Xiong X; Cheung CL; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Chung MSH; Au ICH; Lee CH; Ip TP; Woo YC; Tan KCB; Wong CKH; Wong ICK
J Bone Miner Res; 2024 May; 39(5):551-560. PubMed ID: 38477768
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study.
Raventós B; Pistillo A; Reyes C; Fernández-Bertolín S; Aragón M; Berenguera A; Jacques-Aviñó C; Medina-Perucha L; Burn E; Duarte-Salles T
BMJ Open; 2022 Apr; 12(4):e057866. PubMed ID: 35396302
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.
Perlis RH; Mehta R; Edwards AM; Tiwari A; Imbens GW
Depress Anxiety; 2018 Oct; 35(10):946-952. PubMed ID: 29734486
[TBL] [Abstract][Full Text] [Related]
19. Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study.
Osler M; Jørgensen MB
Am J Psychiatry; 2020 Jun; 177(6):497-505. PubMed ID: 32252539
[TBL] [Abstract][Full Text] [Related]
20. Youth Mental Health Outcomes up to Two Years After SARS-CoV-2 Infection Long-COVID or Long-Pandemic Syndrome: A Retrospective Cohort Study.
Bilu Y; Flaks-Manov N; Goldshtein I; Bivas-Benita M; Akiva P; Bodenheimer G; Greenfeld S
J Adolesc Health; 2023 Oct; 73(4):701-706. PubMed ID: 37389526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]